An open-label, phase I study of the polo-like kinase-1 inhibitor, BI 2536, in patients with advanced solid tumors. (Q53308405)
Jump to navigation
Jump to search
scientific article published on 3 August 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | An open-label, phase I study of the polo-like kinase-1 inhibitor, BI 2536, in patients with advanced solid tumors. |
scientific article published on 3 August 2010 |
Statements
An open-label, phase I study of the polo-like kinase-1 inhibitor, BI 2536, in patients with advanced solid tumors. (English)
Elke Jäger
Ralf-Dieter Hofheinz
Salah-Eddin Al-Batran
Volker L Reichardt
Holger Fritsch
Dirk Trommeshauser
Gerd Munzert
3 August 2010
16
18
4666-4674